malondialdehyde has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Mesery, M; Hazem, SH; Hendawy, OM; Shaker, ME | 1 |
1 other study(ies) available for malondialdehyde and Cytokine Release Syndrome
| Article | Year |
|---|---|
The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice.
Topics: Aldehydes; Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokine Release Syndrome; Dose-Response Relationship, Drug; Inflammation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Nitrates; Nitriles; Nitrites; Oxidative Stress; Peroxidase; Pyrazoles; Pyrimidines | 2022 |